The role of connexin43 in neuropathic pain induced by spinal cord injury

Acta Biochim Biophys Sin (Shanghai). 2019 Jun 20;51(6):555-561. doi: 10.1093/abbs/gmz038.

Abstract

Neuropathic pain is caused by the damage or dysfunction of the nervous system. In many neuropathic pain models, there is an increase in the number of gap junction (GJ) channels, especially the upregulation of the expression of connexin43 (Cx43), leading to the secretion of various types of cytokines and involvement in the formation of neuropathic pain. GJs are widely distributed in mammalian organs and tissues, and Cx43 is the most abundant connexin (Cx) in mammals. Astrocytes are the most abundant glial cell type in the central nervous system (CNS), which mainly express Cx43. More importantly, GJs play an important role in regulating cell metabolism, signaling, and function. Many existing literatures showed that Cx43 plays an important role in the nervous system, especially in the CNS under normal and pathological conditions. However, many internal mechanisms have not yet been thoroughly explored. In this review, we summarized the current understanding of the role and association of Cx and pannexin channels in neuropathic pain, especially after spinal cord injury, as well as some of our own insights and thoughts which suggest that Cx43 may become an emerging therapeutic target for future neuropathic pain, bringing new hope to patients.

Keywords: astrocytes; connexin43; gap junction; neuropathic pain; spinal cord injury.

Publication types

  • Review

MeSH terms

  • Animals
  • Astrocytes / drug effects*
  • Astrocytes / metabolism
  • Carbenoxolone / therapeutic use
  • Central Nervous System / drug effects
  • Central Nervous System / metabolism
  • Central Nervous System / physiopathology
  • Connexin 43 / antagonists & inhibitors
  • Connexin 43 / metabolism*
  • Gap Junctions / drug effects
  • Gap Junctions / metabolism
  • Humans
  • Molecular Targeted Therapy / methods
  • Neuralgia / metabolism*
  • Neuralgia / physiopathology
  • Neuralgia / prevention & control
  • Spinal Cord Injuries / drug therapy
  • Spinal Cord Injuries / metabolism*
  • Spinal Cord Injuries / physiopathology

Substances

  • Connexin 43
  • GJA1 protein, human
  • Carbenoxolone